We support strong biotech initiatives and help drive advancements in bio-services, bio-informatics, gene editing, and neurotechnology:
Bio-Services: Supporting companies that provide contract research, analytical laboratory testing, services, and manufacturing.
Bio-Informatics: Investing in companies that develop tools for analyzing biological data, for making new discoveries and developing innovative products.
Gene Editing: Supporting companies creating and implementing gene editing technologies to modify the genetic code of organisms for therapeutic and agricultural purposes.
Neurotechnology: Funding companies that develop radical technologies to understand and treat neurological disorders, such as brain-computer interfaces and neural prosthetics.
